Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.25M Sell
75,063
-31,178
-29% -$2.23M 0.38% 86
2026
Q1
$4.34M Sell
106,241
-3,400
-3% -$181K 0.26% 130
2025
Q4
$6.52M Buy
109,641
+3,400
+3% +$192K 0.42% 57
2025
Q3
$5.79M Hold
106,241
0.36% 75
2025
Q2
$3.59M Hold
106,241
0.2% 176
2025
Q1
$2.65M Buy
+106,241
New +$3.34M 0.19% 186
2024
Q1
Sell
-49,980
Closed -$1.79M 697
2023
Q4
$1.79M Sell
49,980
-15,550
-24% -$333K 0.2% 172
2023
Q3
$1.11M Buy
+65,530
New +$1.24M 0.14% 263
2022
Q4
Sell
-35,115
Closed -$1.99M 920
2022
Q3
$1.99M Buy
35,115
+7,249
+26% +$339K 0.3% 68
2022
Q2
$945K Sell
27,866
-10,841
-28% -$374K 0.08% 411
2022
Q1
$1.42M Buy
38,707
+12,137
+46% +$555K 0.12% 259
2021
Q4
$1.36M Buy
+26,570
New +$1.37M 0.1% 299

Other funds holding XMTR

PDT Partners's XMTR Position: Q2 2026 in Review

PDT Partners reduced its Xometry (XMTR) stake by 29% in Q2 2026, selling an estimated $2.23M and leaving 75,063 shares worth $7.25M. The position accounts for 0.38% of the portfolio, ranked #86.

PDT Partners first reported a position in XMTR in Q4 2021 and has held it in 12 quarters since. 293 funds tracked by Wall St. Rank hold XMTR as of Q2 2026.

  • PDT Partners held 75,063 shares of Xometry worth $7.25M as of Q2 2026.
  • PDT Partners sold 31,178 Xometry shares in Q2 2026, an estimated $2.23M.
  • Xometry made up 0.38% of PDT Partners's portfolio in Q2 2026, its #86 holding.
  • PDT Partners first reported a position in Xometry in Q4 2021 and has held it in 12 quarters since.
  • 293 funds tracked by Wall St. Rank held Xometry as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.